1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Integra Lifesciences Holdings Corp

Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, Certas® Plus, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MatriStem UBMTM, MediHoney®, MicroFrance®, PriMatrix®, SurgiMend®, TCC-EZ®, and VersaTru®.
Peter Arduini

1100 Campus Road
Princeton, New Jersey 08540
Phone: 16092750500


Integra LifeSciences: Expansion, Audits, and Share Repurchase Plan
May 13, 2024 20:52pm

Integra Lifesciences Holdings Corp. (IART) has provided an announcement. At Integra LifeSciences Holdings Corporation’s 2024 Annual Meeting, stockh…

Headline: Integra Lifesciences Holdings Corp Reports Revenue Decrease in First Quarter of 2024
May 07, 2024 16:59pm

Integra LifeSciences Holdings Corporation, a leading global medical technology company, recently announced its financial results for the first quarter ending March 31, 2024. The company reported a deficit of $-0.04 per share, compared to $0.29 per share a year ago. Additionally, earnings per share fell from $0.25 in the prior quarter. Revenue also saw a decline of -3.144% to $368.87 million from $380.85 million in the corresponding quarter a year ago and sequentially, revenue deteriorated by -7.094% from $397.04 million. This fall in business is not comparable to the relative growth seen in the Medical Equipment & Supplies sector during the same period. Integra Lifesciences Holdings Corp also logged a net deficit of $-3.281 million for the first quarter of 2024, a significant difference from the net proceeds of $24.226 million achieved in the corresponding quarter the previous year. Operating earnings fell by -89.1% to $3.964 million, leading to a decrease in the company''s operating margin from 9.55% in the first quarter of 2023 to 1.07% in 2024.

Truist Securities cuts Integra LifeSciences shares target amid competitive challenges
May 07, 2024 12:02pm


Integra LifeSciences Holdings Corporation (IART) Q1 2024 Earnings Call Transcript
May 06, 2024 17:53pm

No summary available.

Source:Seeking Alpha
Integra LifeSciences slides on FY adjusted profit guidance cut
May 06, 2024 17:50pm

No summary available.

Source:Seeking Alpha
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
May 06, 2024 17:05pm

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of Spirit Airlines, Inc . (NYSE: SAVE ) fell sharply during Monday''s session as the company reported a first-quarter fiscal 2024 revenue decline of 6.2% Y/Y to $1.265 billion, marginally missing the consensus of $1.269 billion. Adjusted EPS loss was $(1.46), down from $(0.82), missing the consensus of $(1.45). Spirit Airlines shares dipped 9.8% to $3.3450 on Monday. Here are some other big stocks recording losses in today''s session. EyePoint Pharmaceuticals, Inc . (NASDAQ: EYPT ) shares fell 37.7% to $12.29 after the company’s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint. Integra LifeSciences Holdings Corporation (NASDAQ: Full story available on Benzinga.com

BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Tuesday, 5/6/2024
May 06, 2024 16:35pm

Stocks that are trading heavily or have substantial price changes on Monday: Paramount Global (PARA), up 32 cents to $13.22. The owner of Paramount Pictures and CBS is reportedly considering a sale to Sony Pictures and Apollo Global Management. Vistra Corp. (VST), up 69 cents to $82.18. The electricity company is being added to the S&P 500 index. Luminar Technologies Inc. (LAZR), down 3 cents to $1.65. The maker of technology for self-driving vehicles is cutting 20% of its workforce. Napco Security Technologies Inc. (NSSC), up $1.16 to $43.64. The security products and software company beat analysts’ fiscal third-quarter financial results. BioCryst Pharmaceuticals Inc. (BCRX), up 87 cents to $5.32. The drugmaker’s first-quarter earnings and revenue beat Wall Street forecasts. Freshpet Inc. (FRPT), up $7.92 to $117.50. The seller of fresh pet food beat analysts’ first-quarter financial forecasts. Integra LifeSciences Holdings Corp. (IART), down $5.58 to $23.31. The medical device maker trimmed its earnings forecast for the year.

Source:ABC 6 News
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
May 06, 2024 15:23pm

Monday, Integra LifeSciences Holdings Corporation (NASDAQ: IART ) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus of $361.96 million and the management guidance of $360 million to $365 million. Revenue increased by 1.6% on an organic basis, excluding Boston . Integra Lifesciences reported an adjusted EPS of $0.55, which is in line with the consensus and lower than $0.74 a year ago. The management had forecasted first-quarter adjusted EPS of $0.53-$0.57 . The company reported adjusted gross margin of 64.4%, compared to 67.3% in the prior year. Adjusted EBITDA for the first quarter of 2024 was $71.8 million, … Full story available on Benzinga.com

Integra LifeSciences beats top-line and bottom-line estimates; initiates Q2 and updates FY24 outlook
May 06, 2024 10:09am

No summary available.

Source:Seeking Alpha
Integra LifeSciences Reports First Quarter 2024 Financial Results | IART Stock News
May 06, 2024 10:00am

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2024. First Quarter 2024 Highlights First quarter revenues of $368.9

Source:Stock Titan